SMTL ID : 7cu5.1

N-Glycosylation of PD-1 and glycosylation dependent binding of PD-1 specific monoclonal antibody camrelizumab

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.81 Å
Oligo State
hetero-2-2-mer
Ligands
1 x NAG- NAG- MAN- MAN- FUC: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x NAG- NAG- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Liu, K. et al., N-glycosylation of PD-1 promotes binding of camrelizumab. Embo Rep. (2020)
Release Date
2020-10-14
Peptides
Programmed cell death protein 1: AD
camrelizumab-scFv: BC
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
Q
D
E
B
B
C
A

Programmed cell death protein 1

Toggle Identical (AD)

camrelizumab-scFv

Toggle Identical (BC)